Cargando…
Adoption and Deadoption of Medications to Treat Hospitalized Patients With COVID-19
OBJECTIVES: The COVID-19 pandemic was characterized by rapidly evolving evidence regarding the efficacy of different therapies, as well as rapidly evolving health policies in response to that evidence. Data on adoption and deadoption are essential as we learn from this pandemic and prepare for futur...
Autores principales: | Barbash, Ian J., Davis, Billie S., Minturn, John S., Kahn, Jeremy M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9333499/ https://www.ncbi.nlm.nih.gov/pubmed/35923589 http://dx.doi.org/10.1097/CCE.0000000000000727 |
Ejemplares similares
-
Catalan experience of deadoption of low-value practices in primary care
por: Almazán, Cari, et al.
Publicado: (2022) -
An administrative model for benchmarking hospitals on their 30-day sepsis mortality
por: Darby, Jennifer L., et al.
Publicado: (2019) -
Willingness to Treat with Therapies of Unknown Effectiveness in Severe COVID-19: A Survey of Intensivist Physicians
por: Levin, Joel M., et al.
Publicado: (2022) -
Medical Wards of the Mercy Hospital
por: Davis, N. S.
Publicado: (1860) -
Medical Wards of Mercy Hospital
por: Davis, N. S.
Publicado: (1872)